MACQUARIE GROUP LTD - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$12,000
-40.0%
0
-100.0%
0.00%
Q2 2022$20,000
-9.1%
4530.0%0.00%
Q1 2022$22,000
-4.3%
4530.0%0.00%
Q4 2021$23,000
-8.0%
4530.0%0.00%
Q3 2021$25,000
+31.6%
4530.0%0.00%
Q2 2021$19,0000.0%4530.0%0.00%
Q1 2021$19,000
-38.7%
453
-32.2%
0.00%
Q4 2020$31,000
+10.7%
6680.0%0.00%
Q3 2020$28,000
-12.5%
6680.0%0.00%
Q2 2020$32,000
-74.2%
668
-75.3%
0.00%
Q1 2020$124,000
-23.5%
2,7000.0%0.00%
Q4 2019$162,000
+5.9%
2,7000.0%0.00%
Q3 2019$153,000
-81.7%
2,700
-82.0%
0.00%
Q2 2019$834,000
+20750.0%
15,000
+14900.0%
0.00%
Q4 2018$4,000
-81.0%
100
-66.7%
0.00%
Q3 2018$21,000
-81.4%
300
-80.0%
0.00%
Q2 2018$113,000
+606.2%
1,500
+400.0%
0.00%
Q1 2018$16,000
-91.2%
300
-91.2%
0.00%
Q4 2017$182,000
-42.4%
3,400
-35.8%
0.00%
-100.0%
Q3 2017$316,0005,3000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders